Tesamorelin | 10mg

Tesamorelin is a synthetic analog of the complete 44-amino acid Growth Hormone Releasing Hormone (GHRH) sequence, stabilized with a trans-3-hexenoic acid modification at the N-terminus. With a molecular weight of approximately 5135.79 g/mol, it is the most complete GHRH analog in clinical and preclinical research use.

Unlike truncated GHRH fragments (e.g., sermorelin at 29 AA, CJC-1295 derivatives), tesamorelin retains the full native GHRH sequence with improved stability. Research has examined tesamorelin’s effects on GH pulse amplitude, IGF-1 levels, visceral adipose tissue, and trunk fat distribution, with a notable evidence base from HIV-associated lipodystrophy studies that produced peer-reviewed pharmacokinetic and pharmacodynamic data.

Each Etched Research vial contains 10mg of lyophilized powder, purity-verified at ≥99% via HPLC and mass spectrometry. Batch-specific Certificate of Analysis included.

Specifications:
– Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S
– Molecular Weight: 5135.79 g/mol
– Purity: ≥99% (HPLC + Mass Spectrometry)
– Form: Lyophilized powder
– Storage: -20°C (lyophilized); 4°C once reconstituted, use within 30 days

FOR IN VITRO RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION, INGESTION, OR ANY IN VIVO USE.